Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-05-13

FDA Approved: LORAZEPAM — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for lorazepam by Hospira, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lorazepam (Lorazepam)

Snippet

SUPPL AP for LORAZEPAM (LORAZEPAM)